REPORT ID 1473

Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Report 2017

Publish Date
06-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the global Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Receptor Tyrosine Protein Kinase Targeted Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Receptor Tyrosine Protein Kinase Targeted Drugs market competition by top manufacturers/players, with Receptor Tyrosine Protein Kinase Targeted Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aslan Pharmaceuticals Pte Ltd
    Boehringer Ingelheim GmbH
    GamaMabs Pharma SA
    Hanmi Pharmaceuticals Co Ltd
    Jiangsu Kanion Pharmaceutical Co Ltd
    Minerva Neurosciences Inc
    Pfizer Inc
    Puma Biotechnology Inc
    Shanghai Fosun Pharmaceutical (Group) Co Ltd
    XuanZhu Pharma Co Ltd
    Zensun (Shanghai) Sci & Tech Co Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Afatinib Dimaleate
    Dacomitinib
    Neratinib
    Neucardin
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Report 2017
1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview
    1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
    1.2 Classification of Receptor Tyrosine Protein Kinase Targeted Drugs by Product Category
        1.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Afatinib Dimaleate
        1.2.4 Dacomitinib
        1.2.5 Neratinib
        1.2.6 Neucardin
        1.2.7 Others
    1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market by Application/End Users
        1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Others
    1.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region
        1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.7 India Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Receptor Tyrosine Protein Kinase Targeted Drugs (2012-2022)
        1.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2022)

2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Players/Suppliers
        2.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Type
        2.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Region
        2.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs (Volume) by Application

3 United States Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    3.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        3.1.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    3.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Players
    3.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    3.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

4 China Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    4.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        4.1.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    4.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Players
    4.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    4.4 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

5 Europe Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    5.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        5.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    5.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Players
    5.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    5.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

6 Japan Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    6.1 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        6.1.1 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    6.2 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Players
    6.3 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    6.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

7 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

8 India Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    8.1 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        8.1.1 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    8.2 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Players
    8.3 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    8.4 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

9 Global Receptor Tyrosine Protein Kinase Targeted Drugs Players/Suppliers Profiles and Sales Data
    9.1 Aslan Pharmaceuticals Pte Ltd
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Boehringer Ingelheim GmbH
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 GamaMabs Pharma SA
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Hanmi Pharmaceuticals Co Ltd
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Jiangsu Kanion Pharmaceutical Co Ltd
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Minerva Neurosciences Inc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Pfizer Inc
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Puma Biotechnology Inc
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 XuanZhu Pharma Co Ltd
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Zensun (Shanghai) Sci & Tech Co Ltd

10 Receptor Tyrosine Protein Kinase Targeted Drugs Maufacturing Cost Analysis
    10.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
    10.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2017-2022)
    14.1